Literature DB >> 6828130

Low-dose steroid therapy for prophylaxis of amiodarone-induced pulmonary infiltrates.

C Zaher, A Hamer, T Peter, W Mandel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6828130     DOI： 10.1056/NEJM198303313081317

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Asymptomatic cavitary pneumonitis due to amiodarone pulmonary toxicity.

Authors:  C J Schechter; G O'Neill; H I Schweppe; T Klima; B Treistman
Journal:  Tex Heart Inst J       Date:  1985-12

Review 2.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

Review 3.  Drug-induced respiratory disorders: incidence, prevention and management.

Authors:  L Ben-Noun
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

Review 4.  Clinical pharmacokinetics of amiodarone.

Authors:  R Latini; G Tognoni; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

5.  Amiodarone-induced pulmonary toxicity mimicking metastatic lung disease.

Authors:  P Patel; D Honeybourne; R D Watson
Journal:  Postgrad Med J       Date:  1987-05       Impact factor: 2.401

6.  Amiodarone pneumonitis: three further cases with a review of published reports.

Authors:  J I Darmanata; N van Zandwijk; D R Düren; E A van Royen; W J Mooi; T A Plomp; H M Jansen; D Durrer
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

Review 7.  Adverse reactions of Amiodarone.

Authors:  Ruben Ml Colunga Biancatelli; Viviana Congedo; Leonardo Calvosa; Marco Ciacciarelli; Alessandro Polidoro; Luigi Iuliano
Journal:  J Geriatr Cardiol       Date:  2019-07       Impact factor: 3.327
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.